Visual function, optic nerve structure, and ocular blood flow parameters after 1 year of glaucoma treatment with fixed combinations

Eur J Ophthalmol 2009; 19(5): 790 - 797

Article Type: ORIGINAL ARTICLE

Authors

Ingrida Januleviciene, Rita Ehrlich, Brent Siesky, Irena Nedzelskiene, Alon Harris

Abstract

Purpose. To compare the effects of latanoprost/timolol (LTFC) versus dorzolamide/timolol (DTFC) fixed combinations on intraocular pressure (IOP), visual function, and retrobulbar blood flow in patients with open-angle glaucoma (OAG).
Methods. This was a prospective, randomized, double masked, parallel study on 30 patients with OAG. All patients received 4 weeks of timolol treatment prior to randomization to LTFC or DTFC treatment. Measurements after randomization were taken at 1, 6, and 12 months, including arterial blood pressure; IOP; color Doppler imaging of the ophthalmic artery (OA), central retinal artery, and short posterior ciliary artery (SPCA); scanning laser polarimetry; Humphrey visual field examination; and adverse events.
Results. IOP decreased by 5.0 mmHg in the DTFC cohort (p<0.000) and 5.44 mmHg in the LTFC cohort (p=0.0001) after 12 months of treatment. No statistically significant differences in visual field or nerve fiber layer thickness were observed between the treatment groups during 12 months of therapy. Mean increase over 1 year of treatment in ocular perfusion and diastolic perfusion pressures were 10.46% and 10.67% in the DTFC group and 7.47% and 5.61% in the LTFC group, respectively. OA resistive index (RI) and SPCA RI were significantly different at the 12 months visit between the two treatment groups (p=0.05 and p=0.000, respectively): DTFC treatment showed decrease in the RI.
Conclusions. One year of treatment with LTFC or DTFC resulted in similar IOP lowering effects as well as stable visual function and structure. The DTFC group showed lower vascular resistance in retrobulbar vessels compared to the LTFC group.

Article History

This article is available as full text PDF.

  • If you are a Subscriber, please log in now.

  • If you are not a Subscriber you may:
  • Subscribe to this journal

    Unlimited access to all our archives, 24 hour a day, every day of the week.

    Article price: Eur 36.00

    You will be granted access to the article for 72 hours and you will be able to download any format (PDF or ePUB). The article will be available in your login area under "My PayPerView". You will need to register a new account (unless you already own an account with this journal), and you will be guided through our online shop. Online purchases are paid by Credit Card through PayPal.

  • Claim online access

    If you hold a Society membership and you have never accessed the website claim online access to receive your log in credentials

No supplementary material is available for this article.

Authors

  • Januleviciene, Ingrida [PubMed] [Google Scholar]
    Eye Clinic, Kaunas University of Medicine, Kaunas - Lithuania
  • Ehrlich, Rita [PubMed] [Google Scholar]
    Glaucoma Research and Diagnostic Center, Indiana University School of Medicine, Indianapolis - USA
  • Siesky, Brent [PubMed] [Google Scholar]
    Glaucoma Research and Diagnostic Center, Indiana University School of Medicine, Indianapolis - USA
  • Nedzelskiene, Irena [PubMed] [Google Scholar]
    Faculty of Odontology, Kaunas University of Medicine, Kaunas - Lithuania
  • Harris, Alon [PubMed] [Google Scholar]
    Glaucoma Research and Diagnostic Center, Indiana University School of Medicine, Indianapolis - USA

Article usage statistics

The blue line displays unique views in the time frame indicated.
The yellow line displays unique downloads.
Views and downloads are counted only once per session.